Altman G B, Lee C A
Department of Physiological Nursing, University of Washington, Seattle, USA.
Oncol Nurs Forum. 1996 Apr;23(3):523-7.
PURPOSE/OBJECTIVE: To review the current use of strontium-89 (89Sr) to treat pain related to bony metastasis secondary to prostate cancer.
Published articles.
Prostate cancer is the most commonly diagnosed cancer in the United States. The disease's most common site of metastasis is the bones. Bone metastasis leads to unrelenting pain. If healthcare providers are able to manage a patient's pain successfully, the patient's quality of life improves.
When conventional therapies fail, 89Sr can be used as an alternative or an adjunct to pain management of bony metastasis in prostate cancer.
Nursing intervention primarily involves assessing pain, monitoring analgesics until 89Sr can begin to take effect, educating patients on using other medications with 89Sr, and assessing fatigue resulting from 89Sr-induced myelosuppression. As pain decreases, nurses also should monitor patients' activity levels, since they are at risk for pathologic fractures.
目的/目标：回顾当前锶-89（89Sr）用于治疗前列腺癌继发骨转移相关疼痛的情况。
已发表的文章。
前列腺癌是美国最常被诊断出的癌症。该疾病最常见的转移部位是骨骼。骨转移会导致持续性疼痛。如果医疗服务提供者能够成功控制患者的疼痛，患者的生活质量将会提高。
当传统疗法无效时，89Sr可作为前列腺癌骨转移疼痛管理的替代或辅助方法。
护理干预主要包括评估疼痛、监测镇痛药直至89Sr开始起效、教育患者如何将89Sr与其他药物联合使用，以及评估89Sr诱导的骨髓抑制所导致的疲劳。随着疼痛减轻，护士还应监测患者的活动水平，因为他们有发生病理性骨折的风险。
